Valeria Da Costa
Montevideo, MO, Uruguay
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Tumor-associated carbohydrate antigens: Biomarker discovery and clinical application.
Journal: Advances in clinical chemistry
Published: August 23, 2025
Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: January 12, 2024
Trypanosoma cruzi-Derived Molecules Induce Anti-Tumour Protection by Favouring Both Innate and Adaptive Immune Responses.
Journal: International journal of molecular sciences
Published: September 13, 2022
Macrophage Gal/GalNAc lectin 2 (MGL2)+ peritoneal antigen presenting cells during Fasciola hepatica infection are essential for regulatory T cell induction.
Journal: Scientific reports
Published: May 26, 2022
Advances in the Immunomodulatory Properties of Glycoantigens in Cancer.
Journal: Cancers
Published: February 13, 2022
Heme-Oxygenase-1 Attenuates Oxidative Functions of Antigen Presenting Cells and Promotes Regulatory T Cell Differentiation during Fasciola hepatica Infection.
Journal: Antioxidants (Basel, Switzerland)
Published: October 02, 2021
Liver function markers and haematological dynamics during acute and chronic phases of experimental Fasciola hepatica infection in cattle treated with triclabendazole.
Journal: Experimental parasitology
Published: September 13, 2021
The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2).
Journal: Cancer letters
Published: April 08, 2021
Eosinophils Control Liver Damage by Modulating Immune Responses Against Fasciola hepatica.
Journal: Frontiers in immunology
Published: July 03, 2020
Last Updated: 09/26/2026